Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Juan Fernando Cueva"'
Autor:
Antonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández-Ortega, Ander Urruticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, José Ponce Lorenzo, María Gion, Patricia Cortez-Castedo, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José Luis Alonso-Romero, Santiago González-Santiago, Eduardo Martínez de Dueñas, Eva Ciruelos, Griselda Martrat, Petra Gener, Daniel Alcalá-López, Miguel Sampayo-Cordero, Fernando Gómez-Peralta, Javier Cortés
Publikováno v:
EClinicalMedicine, Vol 71, Iss , Pp 102520- (2024)
Summary: Background: Hyperglycaemia is an early and frequent adverse event during alpelisib treatment. METALLICA aimed to evaluate prophylactic metformin to prevent or reduce hyperglycaemia occurrence in patients with HR+/HER2−/PIK3CA-mutated advan
Externí odkaz:
https://doaj.org/article/c5ba8bd9a6864624b463e00529accd71
Autor:
Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández, Ander Urriticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, Jose Ponce, Maria Gión, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José L Alonso-Romero, Santiago González-Santiago, Eduardo Martínez De Dueñas, Fernando Gomez Peralta, Eva Ciruelos, José Manuel Pérez-García, Antonio Llombart-Cussac, Javier Cortés
Publikováno v:
Cancer Research. 83:PD8-02
Background: HG is an on-target AE of PI3K inhibition, reported in 63.7% (36.6% G≥3) of HR[+]/HER2[-] ABC patients (pts) treated with ALP plus fulvestrant in SOLAR-1. HG was the most frequent adverse event (AE) leading to ALP discontinuation (6.3%).
Autor:
Rosendo, Bugarín González, Susana María, Romero-Yuste, Paula Mª, López Vázquez, Juan, Casariego Rosón, Nuria, Carballeda Feijóo, Juana Mª, Cruz Del Río, Juan Fernando, Cueva Bañuelos, José Álvaro, Fernández Rial, José Luis, Fernández Trisac, Mª José, Ferreira Díaz, Rafael Álvaro, Millán Calenti, Agustín, Pía Morandeira, Jorge, Prado Casal, Carmen, Rodríguez-Tenreiro Sánchez, Diego, Santos García, Juan Manuel, Vázquez Lago, Mª Asunción, Verdejo González, Irene, Zarra Ferro
Publikováno v:
Revista espanola de salud publica. 94
The health crisis caused by COVID-19 required the prompt launch of research in order to generate scientific evidence pertaining to the new disease oriented to control its devastating effects and continuous spread. Therefore, it was essential to adapt
Second-line chemotherapy with weekly paclitaxel in patients with advanced non-small-cell lung cancer
Autor:
María Calvo Rodríguez, Sonia Candamio Folgar, Begoña Graña Suárez, Luis Leon Mateos, Juan Fernando Cueva Bañuelos, Maria Teresa Curiel Garcia, Francisco Javier Barón Duarte, Rafael López López
Publikováno v:
Revista de Oncología. 4:188-191
In this phase II study we assessed the activity and toxicity of weekly paclitaxel in second line treatment of non-small-cell lung cancer.
Autor:
Jf. Rodriguez-Moreno, Jesús García-Donas, Laia Garrigos, Nuria Laínez, Ana Santaballa, Andrés Redondo, Juan Fernando Cueva, Maria Jesus Rubio, Susana Hernando Polo, Isabel Bover, Isabel Palacio, Zaida Garcia-Casado, Enrique Grande, Alicia Hurtado
Publikováno v:
Journal of Clinical Oncology. 33:TPS5612-TPS5612
Autor:
Elena Brozos Vazquez, Rafael López, C. Lopez, Urbano Anido, Yolanda Vidal, Nieves Martinez Lago, Maria Vieito, Elena Gallardo, Juan Fernando Cueva Bañuelos, Rafael Varela Ponte, Marta Carmona Campos, Santiago Aguin Losada, Sonia Candamio, Francisca Vazquez
Publikováno v:
Journal of Clinical Oncology. 30:e14733-e14733
e14733 Background: Biliary tract tumours are rare and often poor prognosis cancers that comprise cholangiocarcinomas, ampullary tumours and gallbladder cancers. Methods: Medical Electronic Records for patients diagnosed between January 2008 and Decem